Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ER alpha metastatic breast cancer - Magnani, L; Frige, G; Gadaleta, RM; Corleone, G; Fabris, S; Kempe, MH; Vershure, PJ; Barozzi, I; Vircillo, V; Hong, S-P; Perone, Y; Saini, M; et al. (Nature Genetics, 2017)